Ian Haines

Adjunct Clinical Associate Professor, AMREP Department of Medicine, Alfred Hospital, Melbourne & Senior Medical Oncologist and Palliative Care Physician, Melbourne Oncology Group, Cabrini Haematology and Oncology Centre, Wattletree Road, Malvern, Monash University

*Medical Oncology Fellowship- Alfred Hospital, Melbourne 1983-4
*Clinical and Research Fellowship in Medical Oncology, Memorial Sloan-Kettering Cancer Centre, NY, NY 1985-7. (The first Australian to be accepted into this program)
*Palliative Care Physician, RGH, Victoria, 1987-90 (The first such position in Victoria)
*Established and ran first formal undergraduate teaching courses in palliative care at Melbourne University in 1987-90 and Monash University 1991-2004. Details of the Monash course were seen as novel and innovative and were published as a fast-track publication in ‘Psycho-oncology’ in 1994.
*Helped draw up the guidelines for the establishment of first free-standing, dedicated palliative care unit (Fairfield House) at Alfred Hospital Melbourne in 1988.
*Commenced and established the inpatient and day hospital medical oncology service at Cabrini Hospital, Melbourne in 1987, now one of the largest in Australasia.
*Helped to establish the first dedicated and free-standing palliative care unit in the private sector in Australia at Cabrini Hospital, Prahran. This 22 bed unit opened in Nov 1999.
*Helped establish Cabrini’s own dedicated 24-hour domiciliary palliative care nursing service in 1999.
*Visiting Medical Oncologist, Alfred Hospital, Melbourne 1987-2011
*Involved in many oncology clinical trials at Alfred Hospital and Cabrini Hospital.
*Regular teaching of Monash undergraduate medical students in PBL tasks and in private office at Cabrini Hospital, a 550 bed, private not-for-profit university-affiliated acute care teaching hospital.
*Supervisor of Advanced trainees in Medical Oncology/Palliative Medicine
*Various publications on novel therapies; evidence-based clinical cancer research; palliative care; PSA screening for, and treatment of, early stage prostate cancer; alternative cancer therapies; and relationships between physicians and industry.